Home Peptides

Peptides

Latest
Genmab will partner with Immatics Biotechnologies to discover and develop next-generation bispecific cancer immunotherapies through a collaboration that could generate more than $2.8 billion for Immatics. [Rita Elena Serda
Peptides

Genmab, Immatics Launch Up-to-$2.8B+ Cancer Immunotherapy Partnership

Oral delivery method could dramatically transform the way in which diabetics keep their blood sugar levels in check. [Harvard SEAS]
Peptides

Pill May Replace Injection to Deliver Insulin, Other Peptide Drugs

Peptides

PhaseBio Wins $2.8M SBIR Grant to Advance Lead Candidate

A cancer-targeting agent
Peptides

Circulating Cancer Cells Torpedoed by Peptide–Chemo Conjugate

Brain structure
Peptides

Study Sheds Light on How Darkness Produces Dimwits

Peptides

Synthetic Peptides Open Door to New Class of Implantable Medical Devices

In the SLAY method
Peptides

Engineered Bacteria Manufacture and Screen Antimicrobial Peptides against Themselves

An artist's conception of the power of computational design to explore and illuminate structured peptides across the vast energy landscape. [Vikram Mulligan/University of Washington Institute for Protein Design]
Peptides

Advanced Computational Methods May Lead to New Peptide Drugs

Scientists find key target for developing potential Group A Streptococcus vaccine or antibiotic. [NIAID]
Peptides

New Approach Might Provide Potential Treatment for Flesh-Eating Bacteria

Peptides

PeptiDream Inks Peptide Discovery Platform License with Shionogi

Load more

Recently Featured

Stay Connected

556,995FansLike
46,835FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up